AdaptHealth Corp. reported second-quarter 2026 results with revenue up year-over-year while the company recorded a net loss and negative diluted EPS compared with profit in the prior-year quarter.Financial Highlights¹ Reported as “Net revenue”. ² Reported as “Net (loss) income attributable to Adapt…
Q2 2026 saw 12.7% revenue growth to $740.3 million, but a $144.2 million goodwill impairment led to a net loss from continuing operations. Adjusted EBITDA declined to $132.0 million, and a restructuring plan was launched to drive future savings. The pending Diabetes Health business sale and recent…
Organic growth reached 16% with strong gains in Sleep and Respiratory Health, while divestitures and portfolio streamlining refocused the business. Profitability was impacted by West Coast contract inefficiencies and a major supplier price hike, prompting a reset in full-year guidance.Based on Adap…
Organic revenue grew 15.9% year-over-year, but a $144.2 million goodwill write-down led to a net loss and lower Adjusted EBITDA. Guidance for 2026 was revised downward due to discontinued operations and margin pressures, while the Diabetes Health business sale refocuses on core segments.Original do…
AdaptHealth reported second-quarter 2026 net revenue of $740.3 million and Adjusted EBITDA of $132.0 million, while net loss attributable to the company was $145.3 million largely due to a $144.2 million pre-tax goodwill impairment. Organic revenue grew 15.9% year-over-year and the company revised…
Healthcare services provider AdaptHealth Corp. NASDAQ:AHCO will be reporting earnings this Tuesday before market hours. Here’s what you need to know.AdaptHealth beat analysts’ revenue expectations last quarter, reporting revenues of $819.8 million, up 5.4% year on year. It was a mixed quarter for t…
AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that it is divesting its Diabetes Health business to Cardinal He…
